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 Abstract 
 
In South Africa today, it is estimated that there are 6.5 million people living with 
HIV/AIDS, at least half a million of whom require urgent treatment. On the continent of 
Africa as a whole the numbers are even more startling. Unfortunately, although the South 
African government has now committed itself to rolling out anti-retroviral therapy 
through the public healthcare system, progress has been slower than expected. Yet in 
numerous sites around South Africa, rollout centres have been established successfully, 
even in the most rural parts of the country. These programmes rely on existing 
community initiatives, community health workers and volunteers, and positive people 
themselves to educate, counsel, and monitor ARV patients. 
In this study I suggest that this model of care can be extremely empowering for 
the patient and reconceptualises healthcare as a path to social change. Drawing primarily 
from the examples of Madwaleni Hospital in the Eastern Cape, and the Edendale 
community in KwaZulu-Natal. I examine the dynamics of ARV programmes and the 
ways in which they create the "empowered patient"-- one who is knowledgeable, 
articulate, and motivated to effect change in his/her personal life and the social conditions 
under which he/she lives. Finally, I relate the idea of patient empowerment to a 
philosophy of primary healthcare and analyse the potential of primary healthcare to 
improve health in communities through permanent social transformation.  
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Methods 
 
I spent my ISP period in three different locations: Cape Town, the vicinity of 
Edendale Hospital in KwaZulu-Natal, and Madwaleni Hospital in the Eastern Cape. My 
work in Cape Town comprised mainly interviews and library research, while my work in 
KZN and the Eastern Cape involved observation, interviews, and everyday interactions.  
 
Cape Town 
In Cape Town, I interviewed Gilles van Cutsem, a physician at the Khayelitsha 
Site C clinic. I interviewed Gilles to gain a sense of how the doctor’s experience of 
HIV/AIDS care has changed pre and post-ARVs. I was also interested in how he saw the 
role of the medical doctor in the network of relationships that surround the sick in ARV 
treatment. I also interviewed Andrew Boulle, a researcher at the UCT Medical School 
and a physician in Khayelitsha, around similar topics, focusing more on delivery systems. 
 
Edendale, KZN 
In Edendale, I observed a three-day adherence training session run by a team from 
BroadReach Healthcare (BRHC). BRHC is a non-governmental organization that utilizes 
existing resources in communities in ARV rollout. They facilitate relationships between 
private doctors, support groups, treatment buddies, and patients to ensure that patients 
receive treatment, counseling, and psychological support. The three-day adherence 
training session targets new members of BRHC’s ARV care programme. In those three 
days, patients and their “treatment buddies” are educated on the nature and transmission 
of HIV/AIDS, adherence to ARVs, possible side effects on ARVs, in preparation for the 
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 commencement of treatment on the fourth day after the sessions. 
I also held a short focus group session with three members of the BRHC team-- 
Bongani, Zendile, and Themba. All three of them work in different parts of the country, 
coordinating the rollout effort at different sites and facilitating the enrolment process as 
education sessions take place. 
I lived in the home of Molly Kubheka, a support group leader. Thus I also gained 
a great deal of information through formal and informal conversations with her. I also 
spoke to a number of support group leaders, most significantly Nokuthula Biyela and 
Sipho Mncwabe, all of whom act as community facilitators to BRHC.  
 
Madwaleni Hospital, E.Cape 
In Madwaleni Hospital, I spent most of my time with the HIV/AIDS team. I 
observed a morning meeting with the HIV/AIDS team, comprising Dr Richard Cooke, 
ARV clinician; Lynne Wilkinson, site administrator; Christina Kopana and Busiswa Joya, 
peer educators; sisters at the hospital, and community health workers. I spent time 
shadowing one of the peer educators, Christina Kopana in a satellite clinic visit, an 
adherence counsellor, Anemari Buitendach during clinic day at Madwaleni, and also 
followed Christina on her ward rounds to hand out pamphlets and conduct impromptu 
education sessions in wards and waiting rooms. I also observed the proceedings of World 
Aids Day at Madwaleni Hospital. 
Other than observing, I spoke informally to Christina and Busiswa on the topic of 
support groups and their role in treatment, stigma in communities, and adherence and 
education sessions about HIV/AIDS. I also spoke to Lynne during an information session 
about stigma in communities. 
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 Literature Review 
 
In my discussion of the primary healthcare model and its applications to ARV 
care, I refer to the article, Can health promotion and primary healthcare achieve Health 
for All without a return to their more radical agenda?, by Frances Baum and David 
Sanders (1995). This article provides an in-depth discussion of strategies of “health 
promotion” and “behaviour change”—ostensibly part of a primary healthcare agenda—in 
fact fail to conceptualise healthcare in a way that allows it to address problems of 
poverty, deprivation, and disempowerment. Primary healthcare in the era of HIV/AIDS: 
Some implications for health systems reform by Petersen & Swartz provides a more 
theoretical framework to understand the subversion of  “expert” power and patient 
empowerment in HIV/AIDS treatment.  
There is a wealth of research on community-based healthcare and activism around 
HIV/AIDS in the developing world, including From Directly Observed Therapy to 
Accompagnateurs: Enhancing AIDS treatment outcomes in Haiti and Boston by H.L. 
Behforouz, P.E. Farmer, and J.S. Mukherjee (CID supplement 5, 2004:38); and 
Community-based approaches to HIV treatment in resource-poor settings by Farmer P, et 
al (Lancet 2001; 358: 404-9). Specific to South Africa, Outcomes after two years of 
providing antiretroviral treatment in Khayelitsha by Coetzee, D., et al provides an insight 
into the clinical aspects of the first ARV rollout site in South Africa; The Impact of ARV 
Provision on HIV/AIDS Prevention by Jo Stein (AIDS Bulletin, March 2005); Building 
‘AIDS-competent communities’ by Catherine Campbell, Yugi Nair, Sbongile Maimane 
and Zweni Sibiya (AIDS Bulletin, September 2005). These articles examine the role of 
community support structures—including community health workers, support groups and 
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 faith-based organizations—in ARV treatment. The Impact of ARV Provision on 
HIV/AIDS Prevention in particular focuses on the potential for the effects of treatment to 
spill over into prevention efforts, for example in lessening stigma around HIV/AIDS, 
encouraging testing, etc.  
Two fascinating articles on the history of patient-led activism in South Africa can 
be found in the volume Democratising Development: The Politics of Socio-Economic 
Rights in South Africa (Jones P & Stokke K eds, 2005). The first, Shaping, Making and 
Breaking the Law in the Campaign for a National HIV/AIDS Treatment Plan by Mark 
Heywood (2005) tracks the strategies of the Treatment Action Campaign (TAC) to situate 
the language of HIV/AIDS struggle in human rights discourse. The second, The TAC and 
the History of Rights-Based, Patient-Driven HIV/AIDS Activism in South Africa by 
Mandisa Mbali (2005) describes the roots of “patient activism” and the effects of the 
TAC’s “campaign for openness” in the early 1990s.  
Last but certainly not least, for critiques of market-driven healthcare and concepts 
of “sustainability” and “cost-effectiveness” as philosophically flawed arguments that 
prolong suffering in the developing world, refer to Pathologies of Power: Health, Human 
Rights, and the New War on the Poor by Paul Farmer (2005) as well as Against Global 
Apartheid by Patrick Bond (2001).   
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 Limitations of Study 
 
This study was first of all limited by time. Spending 4-5 days in each site gave me 
time to speak to several people involved in HIV/AIDS care, but often did not give me the 
opportunity to observe their general routine and their work with others. A longer time in 
communities would also have given me the opportunity to gain a better sense of the 
communities in which I was researching. 
In the study, most of the people I cite either work in the field of health, or are 
positive people who have been trained to play a support role in ARV treatment. I consider 
it a great honour to have met them and heard their insights. For a project that repeatedly 
emphasizes patient-centred healthcare, however, I did not manage access to patients who 
were not also in the position of activist, support group leader, counselor, peer educator… 
I was also constrained in this respect by the language barrier, since many patients did not 
speak English. 
As a perhaps overly-optimistic study on the positive impact of ART, this report 
perhaps concentrates on better- developed ARV programmes that do not reflect the state 
of ART provision in South Africa. It could also consider in greater depth the modes of 
delivery and evaluate the impact of ART accordingly. In other words, the existence of 
education does not mean education is effective; and existence of counseling does not 
mean that patients are necessarily changing their behaviour.  
 Lastly, ARV treatment is relatively new to South Africa, and a study of its impact 
may be premature. More importantly, this study essentially examines the growth of 
personal agency through a model of healthcare provision. While this looks optimistic, the 
initial positive impact on small groups of people living with HIV/AIDS may be diffused 
as programmes are scaled up and become more impersonal.  
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 Introduction 
 
Since the inception of the South African National AIDS Plan in 1994, it has been 
accepted, in theory at least, that HIV/ARV care should exist within a primary healthcare 
system. The National AIDS Plan prioritized not simply medical care, but also education, 
prevention, counselling, human rights, welfare and research. (Marais, 2000) 
Unfortunately, implementation of the National AIDS Plan failed to materialize, and 
AIDS care was further jeopardized in the late 1990s and early 2000s by suspicion of 
antiretroviral therapy (ART) and arguments that alleviating poverty should be prioritized 
over HIV/AIDS care (Mbeki, 2003). Others argued that one cannot expect poor, 
uneducated populations to stay on lifelong drug regimens requiring >95% adherence—
certainly, the developed world has not done spectacularly on that count either.  
More fatally, arguments against ARV treatment (including the prevention of 
mother-to-child transmission) subscribe to market-influenced conceptions of medical 
care, which employ cost-effectiveness and sustainability assessments in decision-making. 
Joia Mukherjee, a physician with Partners in Health, points out the contradictions of this 
framework, and its failure to serve those in resource-constrained settings:  
 
“The first (argument)… is that ‘we have limited resources, can we figure 
out what gives us the biggest bang for the buck?’ That is the ‘small pie’ argument. 
The second big argument is ‘even if you had all the money in the world, the 
infrastructure is lacking so you cannot just throw money at a problem.’” 
(Interview in AIDS Bulletin, September 2005) 
 
This represented a philosophical shift away from the primary healthcare model, in which, 
as Baum and Sanders put it, "considerations of equity, intersectorality and community 
involvement were dismissed in favour of technical feasibility and cost-effectiveness of 
programs." (1995) 
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 It was further suggested that providing a complex drug adherence requiring strict 
adherence to poor and largely uneducated peri-urban and rural populations would be 
virtually impossible. (Interview with Hermann Reuter, AIDS Bulletin, March 2005) 
Thus, when Medecins Sans Frontiers (MSF) set up the first ARV clinic in South Africa in 
1999, in the township of Khayelitsha just outside Cape Town, there was a great deal of 
skepticism as to its viability. Six years later, management of the Khayelitsha clinics has 
been largely transferred to the provincial government. A new MSF pilot project in 
Lusikisiki, in the rural Eastern Cape, recently enrolled its 1000th patient onto ART. 
Adherence rates in Khayelitsha stand at approximately 70%, far higher than rates in 
Europe and North America, which stand at approximately 40%. 1
The notion that complex drug regimens can be understood and adhered to in areas 
like Khayelitsha and Lusikisiki has deeply jolted the assumption that the poor sick are 
unsuitable candidates for ART. More crucially, it has resurrected the focus on primary 
healthcare as a philosophy for HIV/ARV care by showing how healthcare can be 
delivered in a viable, “sustainable“ fashion in resource-poor communities.  
In delivering HIV/ARV care in the peri-urban and rural communities of 
Khayelitsha and Lusikisiki, MSF marshalled forces within the community, involving 
counselling, support group participation, and community health workers in the treatment 
programmes. In particular, the Treatment Action Campaign (TAC) provided volunteers, 
treatment literacy educators and lay counselors in support of the MSF effort. The TAC 
also played an important role by encouraging disclosure and organizing patient-led 
campaigns and movements. 
MSF’s success in forming partnerships within the community to deliver quality 
                                                          
1 Statistics provided by Gilles van Cutsem, MSF, Khayelitsha 
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 ARV treatment demonstrates the notion that how treatment is delivered should receive 
equal attention as the fact that treatment is provided at all. This question becomes 
especially crucial in an epidemic so strongly associated with intimate questions of sex, 
shame, and death, as well as with social issues of ignorance, stigma, gender inequality, 
and poverty. By incorporating support groups, disclosure counselling, and education into 
ARV programmes, these programmes acknowledge the responsibility of public health 
towards both the sick and towards understanding the social context of sickness. Within 
this framework, treatment becomes an opportunity for personal empowerment and social 
transformation.  
In this study I focus on the empowering nature of ARV care in resource-
constrained settings, drawing from examples of treatment sites in Khayelitsha in the 
Western Cape, Madwaleni Hospital in the Eastern Cape, and in the Edendale community 
in KwaZulu-Natal. I examine how patient empowerment takes place through learner-
oriented education, adherence and disclosure counselling, and through the privileging of 
the patient’s subjective experiences of sickness in support group settings; and 
demonstrate the ways in which the primary healthcare approach of these ARV 
programmes has created the "empowered patient"—one who is knowledgeable, articulate, 
and motivated to effect change in his/her personal life and the social conditions under 
which he/she lives. Finally, I consider the ways in which the philosophical underpinnings 
of these HIV/ARV programmes creates opportunities for South Africa to reconceptualise 
primary healthcare to not only provide access to care for all, but also to act as a change 
agent within communities.  
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 I. Patient-Centered Education : Treating the patient as a learner 
 
ARV treatment, as my host Molly Kubheka put it, turns AIDS from a “death 
sentence” into a “life sentence”. The rigidity and complexity of the drug regimen, 
combined with the need for high adherence rates (>95%) to prevent resistance, present a 
huge challenge to any patient—and not least, patients who struggle under conditions of 
poverty and deprivation. Because of this, the consensus on several fronts has been that 
adequate preparation is needed before a patient can go on ART. Patient education was 
taken extremely seriously in both the BroadReach site in Edendale, and at Madwaleni 
Hospital. In this section I describe my observations in adherence training and counseling 
sessions in both sites, and suggest that the reorientation of health education to engage and 
involve patients contributes greatly to the process of patient empowerment through 
treatment. 
 
Observations at BRHC adherence training  
The team from BRHC conducted an adherence training session that lasted three 
full days (8.30am-4pm) for the 50 new patients enrolled on the ARV program, and their 
treatment buddies. The sessions were conducted in isiZulu and translated for me in part 
by Nokothula Biyela, a Siyaphila support group leader. I was present for the first two 
days and half of the third day.  
Despite the large audience, the training sessions were highly interactive. Zanele, 
BRHC’s Information, Education and Communications (IEC) coordinator, led the session. 
She opened the session by asking what expectations the patients and buddies had of 
BroadReach, of ART, and HIV. A wide range of statements and questions were supplied, 
including:  What happens if you stop ARVs after 2 months and start again? What changes 
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 will appear in my body after ARVs? How do I look after my nutrition and diet? How do I 
encourage my partner to go for a test? These questions were written down on large pieces 
of paper and put up on a wall inside the room. Zanele promised to address all questions in 
the next three days. She then gave a short introduction to BroadReach, framing the 
treatment program as a partnership in which BRHC, the support groups, and the patients 
had equal responsibility.  
The first day of the training session focused on introducing patients to the 
program, and educating them on HIV/AIDS, how the virus works in the body, modes of 
transmission, and opportunistic infections. The group was shown a series of pictures and 
asked to form a story around them. In the first picture, a woman was shown walking 
alone down a road in a village. The group named the woman “Katiwe”. Some suggested 
that she was going to visit a friend, and others that she was beginning a journey. The next 
picture showed two women sitting outside a house, and the group suggested that Katiwe 
was disclosing her status to a friend. Zanele then asked the group: now that you have seen 
where and how Katiwe lives, how do you think she got the virus? There was a range of 
answers; some said that she had been caring for a sick HIV patient and was exposed to 
blood, while others said that her husband works in a mine in Johannesburg and infected 
her with the virus. 
This became a discussion on how HIV is transmitted. Attendees were asked to 
suggest other ways in which you could get HIV, besides unprotected sex. (Ideas included 
sharing toothbrushes, being pricked by needles, blood on toilet seats, etc) Each idea was 
discussed by the group and finally rejected or accepted. The group went through a series 
of pictures in this fashion, and ended (for the day) with Katiwe in the doctor’s office.  
For the second half of the day, the group was educated on how the HIV virus 
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 works inside the body. The analogy of the CD4 “soldier” was used to explain what the 
CD4 count meant, and also the processes by which the virus multiplies inside the body. 
The second day of training focused on adherence and ARVs. Zanele opened the 
session with a discussion of the English word “adhere” and “adherence”, asking the 
group about what they associated with the words. The idea of “itape” was mooted and 
discussed briefly, as well as the idea of “sticking to the rules”. Around the issue of 
adherence, Zanele facilitated discussions on disclosure and the importance of disclosure, 
support groups, and explained the need for “triple therapy”.  
I attended the second half of the third day, after a focus group session with the 
BRHC team. The third day consisted of role-plays put up by the facilitators from the 
support groups, and large group discussions where the whole group sat in a large circle. 
Later the group broke into four smaller groups, where they reviewed the information they 
had received over the past two and a half days, and presented it to the group.  
 
Observations at Madwaleni Hospital adherence counselling 
 
In Madwaleni Hospital, I had the opportunity to sit with Anemari Buitendach and 
her assistant/ interpreter, Zameka Ntibane, for a day of adherence counseling and follow-
ups. Anemari is a pharmacist by training and is in charge of issuing pills to both new and 
old patients every month.  
Before each existing patient could get a new supply of ARVs, he/she had a 15-20 
minute conversation with Anemari about his/her experience of the past few months. 
Besides asking about side effects, Anemari concentrated on two aspects regarding 
adherence. She typically asked every patient what he/she was doing to ensure adherence. 
Some patients said they set watch alarms, while others timed their medicines by events in 
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 the day—one man said he would wake up, take his medicines, then let the cows out; and 
at the end of the day, herd the cows back in, and take his second dosage. Secondly, she 
was concerned about the hospital-provided “treatment diary” and the “treatment buddy”, 
and whether these were helping the patient. Almost all the treatment diaries I saw that 
day were neatly filled in, and patients acknowledged that these forms were useful. Most 
also agreed that the treatment buddy was helping, especially if the buddy was part of the 
family and lived in the same house.  
The general sentiment in these sessions was that the ARVs were “very right 
kakhulu”. Patients enjoyed sharing their stories and reporting successes, such as weight 
gain or re-commencement of work. Patients also reported being constantly hungry. 
I also observed an hour-long “training” session that patients have to attend, on a 
one-on-one basis with Anemari, before they are given their first month’s supply of 
ARVs. The patients—a married couple—seemed to already know a great deal about 
ARV care. They could report the names of their medicines (3TC, D4T, efivirenz for the 
husband, and nevirapine for the wife), and could demonstrate the order in which drugs 
should be taken (2 in the morning, and 3 in the evening. The wife also appeared to be 
familiar with the side effects of nevirapine on the liver. Anemari further explained the 
effects of ARVs on the virus, and the importance of adherence.  
The second half of the session focused more on practical measures that would aid 
adherence. The couple was asked where they would put their ARVs and if they would be 
easily visible. They also were taught how to fill their own pillboxes, and how to use the 
pillboxes and the treatment diary. There was a small struggle with relating the English 
initials on the pillboxes to the days of the week in isiXhosa, and how the compartments 
of the pillboxes worked. 
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 I spoke to Anemari later on the protocol the hospital uses for adherence training 
and her personal philosophy towards it. She emphasized the need to “not treat an adult 
like a child”, and to help patients become responsible for their own treatment. She also 
noted the importance of support groups as another source of information, where positive 
people on ARV treatment can talk about methods of adherence and act as a source of 
inspiration and encouragement for each other.  
 
Interactive education as a form of empowerment 
 
Adherence training is unique to the developing world, driven primarily by a need 
to prevent drug resistance in the two drug regimens supplied in South Africa. Marcus 
McGilvray, IEC coordinator of BRHC, pointed out that the very existence of “adherence 
training” is a new concept that is significant in itself. (21/11/05) The impetus for 
developing education programmes for patients came from the high dropout rates from TB 
treatment programmes, even where directly observed therapy was utilized. ARV care 
thus took lessons from the failure of TB care in designing a more patient-centred 
approach to treatment delivery.   
Because there is no precedent to “adherence training” in the developed world, 
adherence training programmes in South Africa and the developing world were designed 
on an “ad-hoc” basis. BroadReach Healthcare’s training model draws upon “the culture 
of storytelling, which is typical to African culture.” (06/12/05) Thus several of the 
exercises, as described above, involve forming narratives around HIV/AIDS and drawing 
lessons from them—for example, the picture exercise, and the analogy of the CD4 cell as 
“soldier.” Marcus suggested that, although little research has been done on the topic, it 
seems the more patients understand about HIV, side effects, and resistance, the more 
 17
 likely they are to adhere to drug regimens. “It’s essentially active learning,” he 
commented, noting that a great deal of research has been done on topics such as learner 
involvement in education. (06/12/05) 
However, Marcus pointed out several areas of the BRHC model that need to be 
further developed. The lack of one-to-one counseling by qualified counselors, for 
example, makes it close to impossible to find out what stage an individual is at in terms 
of psychological well-being and behavioural change. The cycle of first accepting one’s 
status or condition and then changing one’s behaviour is necessarily disrupted or restarted 
by side effects of ARVs. Thus one-on-one consultations with trained counselors are an 
imperative in ensuring drug adherence. (06/12/05) 
The need to involve patients in learning around their own condition and treatment 
has become essential in any model of ARV delivery. But implementation of educational 
development theories are often constrained by factors ranging from a lack of personnel to 
poor choice of venue. Fundmentally, the belief remains that patients must possess 
understanding ways that they previously did not, with TB-DOTS, for example. Yet, the 
effectiveness of education is intricately linked with a need to understand and monitor the 
psychological condition of the patient. In the following section, I discuss the role of 
counselling and support groups in treatment, and the process by which patients come to 
accept their condition and develop a sense of community around being HIV positive. 
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II. Linking the medical and the psychosocial: Promoting openness and dialogue 
about AIDS 
 
 
The condition of disclosure 
 
In both programs I visited, disclosure was a prerequisite to the commencement of 
ART. The patient is encouraged to first disclose his/her status to at least one more person, 
with the dual assumption that 1) this person can become a treatment “buddy” or at least 
provide frequent reminders to the patient and 2) that a patient who has not disclosed 
his/her status still struggles to accept his/her status, and therefore is not yet the best 
candidate for lifelong ART.  
The link between disclosure and adherence places unprecedented import on the 
psychosocial experience of the patient in medical treatment. It recognizes a link between 
the psychological and the physical experience of illness—that stigma within the 
community can impact a patient’s ability to adhere to treatment. This cuts a contrast to 
conceptions of compliance that rely on physicians’ assessment of “social worthiness” 
(e.g. alcoholism, inclination to violence) or educational status. (Farmer, 2005; Stein, et al, 
2005) Furthermore, the emphasis on disclosure as a precondition to treatment creates a 
necessary journey that patients must make—towards accepting their own condition and 
finding pride in their personal act of disclosure. 
In Edendale, I asked several support group leaders about conditions promoting 
adherence. My question was met with virtually the same answer each time: that people 
default on ARV treatment because they had not come to terms with their positive status. 
Sipho Mncwabe, the chairperson of support group Sbongukuphila in Edendale, said: 
 
“Sometimes people hide their pills from their family, they don’t put it in 
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 the kitchen so they forget to take it, or the family will ask, ‘why are you taking 
these pills?’ That’s why people must disclose… People are staying together in one 
house but no communication, because they are scared to address their status.” 
(24/11/05) 
 
Molly Kubheka, founding member of Siyaphila, an umbrella support group for 
groups in the Pietermaritzburg area, noted that there is a small minority of people who are 
“just not committed”, but for the most part, people don’t adhere because  
 
“they are still hiding their status, they don’t dare to take their pills in front 
of their family.” (24/11/05) 
 
Similar sentiments were echoed at Madwaleni Hospital. During a morning 
meeting for the HIV/ARV team, a support group leader suggested that using disclosure as 
a prerequisite to treatment might constitute a form of discrimination, or violation of rights 
on the part of the patient. Several of those present at the meeting disagreed with the 
statement, insisting that adherence to ARVs was impossible if treatment was taken in 
secret. Busiswa argued that lifelong treatment cannot be a solo effort. 
 
“Sometimes I even forget to take the ARVs, and my mother will remind 
me, or my family will remind me. So I think if you say you don’t have to tell 
anyone, and you can do it by yourself, it is not like that.” (28/11/05) 
 
 Lynne Wilkinson, site administrator for the ARV program, noted that  
 
“No one has ever refused a treatment buddy on the grounds that they feel 
completely competent… Mostly it is because they are afraid to disclose their 
status.” (28/11/05) 
 
In general there was a great concern for the patient’s psychological condition and 
the effect this would have on successful treatment. Healthcare workers and counselors 
saw the act of disclosure as an empowering act, signifying personal reconciliation with 
the illness. Christina Kopana, a peer educator at Madwaleni Hospital, described the 
support they provide to patients regarding disclosure. 
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“We ask them to draw a family tree… then we see, who is suitable for the 
patient to tell. If they draw a tree and the father is an alcoholic, or the mother left 
the patient years ago, we don’t advise them to disclose to them. We find the best 
person and teach them how to disclose.” (30/11/05) 
 
Busiswa, another peer educator, herself HIV positive, said that people now “feel 
bold, and can go home and disclose.” Further, in this process, counselors find themselves 
becoming more involved with the social and personal aspects of patients’ lives. Busiswa 
recalled an incident after a support group meeting where a woman realized that her 
husband who works in Johannesburg must have infected her: 
 
“She said she wanted to call her husband in Jo’burg and scream at him, 
‘how can you sleep around and give me AIDS?’ So I had to say, no, that is not 
how you should do it, you must wait for him to come home and talk about it.” 
(28/11/05) 
  
Furthermore, it has been argued that the act of disclosure signifies more than an 
acceptance of one’s medical condition and the determination to change it. It represents a 
defiant exercise of individual agency despite the risk of discrimination, rejection and 
exclusion. Mandisa Mbali writes, 
 
“As the first few brave openly HIV positive AIDS activists stepped 
forward, it showed that the right to confidentiality did not have to mean enforced 
secrecy, nor did people living with HIV have to give all their power to the doctors 
treating them; they had the right to either hide or reveal their HIV status, showing 
their agency in forming strategies and tactics to resist AIDS-related 
discrimination.” (2005) 
 
In this sense, disclosure becomes an act of self-definition and empowerment. The 
condition of disclosure then signifies a renewed emphasis on the patient’s psychosocial 
condition in successful treatment. Inside this framework, it becomes possible to subvert 
the power of “experts” to predict categorically whether a patient can or cannot be 
compliant— an exercise long considered largely fruitless (Farmer, P. et al, 2004). The 
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 patient is seen as a human being who can be empowered to act under social constraints, 
which are themselves changeable through public health measures. Healthcare workers 
invariably become more involved in patients’ social realities and their personal journeys 
towards acceptance and disclosure. The healthcare sector thus takes on a new role of 
empowerment, one that is deeply embedded in social transformation.  
 
“It’s not just me, now it’s us” 
 
The task of ARV programmes to provide psychosocial support so as to ensure 
adherence, as I discussed in the previous section, has resulted in an expansion of 
networks surrounding the sick. There is an increasing awareness of the need to tend to the 
sick and the experience of sickness outside the doctor’s office. (Brouard, 2005) Thus, 
support groups, which provide a space for patients to discuss their HIV status and also 
their experience with ARVs, have become a central part of many ARV programs. Molly 
put it this way: 
 
“The doctor will only see you for a few minutes, but the support group is 
always there.” (24/11/05)  
 
The support group establishes a dialogue among patients where patients can learn from 
each other and derive encouragement from shared experience. Referring to her 
community in the township of Imbali, Edendale, Molly stressed the importance of 
structures of support to the sick. She pointed out the frustration that positive people feel 
about their status and the “life sentence” of ART, as well as the need to provide a space 
to talk about negative and positive experiences alike. 
 
“Some days I just look at the pills and push them into my mouth, I’m so 
cross about taking the pills… Sometimes you see people coming out of the clinic 
and their test results are negative, and you think, ‘why me? What did I do?’ But 
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 with the support group, it’s not just ‘me’, now it’s ‘us’, that’s why support groups 
are so important.” (24/11/05) 
 
The social capital that grows out of knowledgeable and empowered patients, able 
to provide support to others, plays a huge role in ARV programmes. Anemari, the 
pharmacist for the Madwaleni HIV/ARV programme, observed that ARV patients 
themselves are themselves a great source of encouragement and support to newer 
patients, and make a great contribution to the rollout process. (29/11/05) This is what 
Farmer (2004) refers to as the “virtuous social cycle” that arises out of treatment 
programs, where “neighbours are enlisted in the struggle against tuberculosis and HIV 
infection.”  
Where the function of the medical doctor shrinks into a larger system including 
support networks, counselling and education, healthcare can begin its descent from the 
arena of “expert” knowledge and engage patients on the layperson’s level. Gilles van 
Cutsem, a doctor at the Khayelitsha Site C clinic, noted that the ARV programme run 
jointly by Medecins Sans Frontiers and the Western Cape province uses lay counselors, 
treatment literacy educators, and support groups help to demystify potentially confusing 
medical explanations. Gilles observes, 
 
“The language the doctor uses is rarely appropriate... We rely a lot on the 
counselors to transmit information and explain things to patients.” (16/11/05) 
 
Furthermore, advice given by support group members has the benefit of personal 
experience, which can often be comforting and encouraging as well. Gilles commented, 
describing the crucial role of support groups in ARV programs, 
 
“If the patient comes to you with a rash, you can say oh it’s normal, it will 
go away… but in the support group, someone will say, I understand, that 
happened to me two months ago, its normal… sometimes that is more effective 
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 than the doctor.” (16/11/05) 
 
I observed two support group meetings during my time at Madwaleni Hospital. 
The first took place at the hospital itself, and comprised mostly patients who were being 
prepared for ARV treatment. I struggled to follow the session with my thin understanding 
of Xhosa, but was able to get a general sense of the proceedings. Sister Willie from the 
HIV/ARV team led the session. All the new faces in the room—myself included—
introduced themselves, and were welcomed by Sister Willie.  This was followed by short 
introductions from some of the older members of the support group, one or two of whom 
had already started ART. For the next hour or so, Sister Willie led a conversation with the 
group, addressing individuals and answering questions about ART. Lynne Wilkinson, the 
site administrator for the Madwaleni HIV/ARV programme, later commented that one 
probably did not need to understand Xhosa to get a sense of how the support group 
operated—it was apparent from the Sister’s tone of voice, her encouragement of the 
quieter members of the group, and the evident engagement of majority of people in the 
room—despite frequent interruptions by crying babies and ringing cellphones.  
The second support group meeting I attended took place in Nkanye clinic, about 
40 minutes away from Madwaleni. This was a smaller support group for both patients 
already on ART and those being prepared for ART. At the start of the session, members 
stood up and introduced themselves, and stated the date on which they began ART. One 
of the sisters of the clinic led the session. A lively and informal discussion ensued, 
apparently sparked off by one member’s description of the rash he got from the ARVs. 
As new members filed in, they were welcomed warmly with songs. Most striking in the 
Nkanye session was the use of music to convey messages about HIV and ARV. One song 
roughly translates to, “Me, I have tested for HIV/AIDS, have you?” Another one 
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 appeared to be a call to treatment, and involved complex medical terms such as 
“cryptococcal meningitis”, “fluconozale”, and “nevirapine”.  
The familiarity of all the support group members with terms that other non-
medical people routinely trip over only emphasized the notion that the poor, uneducated 
sick can indeed attain extensive knowledge about their medical condition. This 
phenomenon is not unusual: it has been observed from Lusikisiki in the Eastern Cape, to 
Cange, a slum area in Haiti (Farmer, 2005): 
 
“(in Lusikisiki) Before long, people… were donning HIV-POSITIVE T-
shirts, singing about the virtue of condoms and quizzing each other on the 
difference between a nucleoside-analogue reverse transcriptase inhibitor and a 
non-nucleoside-analogue reverse transcriptase inhibitor.” (Newsweek, 
19/04/2004) 
 
The role of support groups in ARV treatment cannot be overemphasized. Because 
of the psychological support and education received in preparation for ARVs, patients on 
treatment are mentally and physically more empowered than other members of the 
community. They have more knowledge about healthcare and nutrition, are familiar with 
the biomedical processes of the virus and complex drug names; most of all, having 
trodden the difficult path of personal acceptance, disclosure and finally treatment, they 
are in the best position to give advice to other positive people. 
It is perhaps difficult to grasp the magnitude of empowerment that takes place 
when positive people come to play an equally important role—some argue, a more 
involved role—in treatment than healthcare professionals themselves. It has been argued 
that the ability of the support group structure to build confidence in more withdrawn 
members contributes significantly to the empowering effect of ARV treatment. It 
certainly takes courage to speak about one’s own condition in front of a group of at least 
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 twenty individuals. As a result, many of the HIV positive people in Madwaleni and 
Edendale were extremely articulate about their own condition, and came to play an 
increasingly visible role in awareness-building, prevention, and treatment activism.  
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 III. “Amandla Ngawethu”: Patient-centered Activism  
 
On World Aids Day, all the support groups from the clinics on the Madwaleni 
HIV/ARV program came together in the church at Madwaleni Hospital. Support group 
members sat in the church waiting for the program to begin, as gospel music and songs 
about HIV/AIDS played on the sound system. Then a recording of a rally for treatment 
came on, declaring “Amandla!” The support group members sitting in the pews raised 
their fists and chanted, together with the recording, “Ngawethu!” “Amandla!” 
“Ngawethu!”2
This spectacle represented to me the power of positive people themselves to effect 
change in their communities—to demand treatment, to educate others against stigma and 
ignorance, and raise awareness about prevention. In both Edendale and Madwaleni, 
support groups comprising positive people, many receiving treatment, formed the 
backbone of movements within communities to educate their communities, and to 
reclaim the right to be respected as a healthy and normal member of their communities. 
In this section I draw a link between patient empowerment through treatment as 
discussed in the previous section—where patients are educated and counseled so that they 
can take responsibility for treatment—and patient “activism”, where positive people 
stand at the forefront of efforts to halt the spread of the epidemic. 
 
The unwitting activist: Impact of ART on perceptions of HIV 
 
It has been suggested that the fact of treatment can be a mode of activism in itself, 
where the visible effect of ARVs to “literally resuscitate people” lessens collective 
                                                          
2 “Amandla Ngawethu” translates to “the power is ours”. This chant was often used during anti-apartheid 
protests. Its use today situates the struggle for the rights of people living with HIV/AIDS as analogous to 
the struggle of the 80s: militant, unrelenting, and proud. See Mbali, 2005  
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 suspicion towards the disease and also towards positive people. (Gilles van Cutsem, 
16/11/105) Echoing Paul Farmer’s assertion that “if care is available, stigma goes away”, 
Gilles van Cutsem from the Khayelitsha Site C clinic held that the availability of 
treatment has increased the willingness of people to test for HIV, and aided the 
movement towards openness and disclosure. (AIDS Bulletin, June 2005) 
 
“When we first started, stigma in the community was very large. HIV was 
always seen as someone else’s disease. So everyone said, ‘nobody will come’ (to 
the clinic)… In the first year, 1999, we had just over 100 people testing. Now we 
have thousands testing a year.” (16/11/05) 
 
During a focus group session with three members of the BroadReach team, I 
asked if they had observed any changes in the communities in which they work as the 
roll-out continues. The positive impact of ART was recognized emphatically by all 
members. Bongani Nkosi, regional coordinator of Mpumalanga, described his 
experiences in an unnamed community where stigma was very high. He recalled their 
modest expectations at the start of the BRHC intervention given the level of stigma in the 
community, and compared it to the expected turnout at the upcoming enrolment: 
 
“This time we are expecting about 150 patients, which is very big, we’ve 
never seen those numbers before. And so I think treatment itself breaks down 
stigma. People usually think HIV patients are very sick, cannot move, are dying, 
but then they see that positive people can lead a normal life… And so I think over 
time people will start to see HIV/AIDS as just another kind of disease.” 
(23/11/2005) 
 
Zandile Wanda, the regional coordinator for KwaZulu-Natal, agreed that there 
was potential for change, but pointed out that societal stigma remained high. She cited the 
local support group Siyaphila as an example of persistent ignorance and discrimination 
against positive people. Members of Siyaphila hold support group sessions at a nearby 
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 “drop-in” center for hospice care; in the kitchen, they are not allowed to share silverware 
with the rest of the center. She stressed that it will take a long time, and lots more 
education in communities, for them to fully accept positive people. Still, the team 
remained optimistic on most counts. They acknowledged that the mere sight of someone 
coming with someone positive was a great thing, given the level of stigma “by 
association”— as Bongani put it— that existed previously. 
Indeed, it has been argued that because ARV provision decreases the perception 
of HIV/AIDS as a “death sentence”, it is likely to decrease the fear around infection and 
by extension stigmatisation of HIV-positive people. Stein (2005) argues that the fear of 
infection does not in fact lead to safer sexual behaviour, but rather a continued rejection 
and denial of the virus and of others infected by the virus.   
 
“The logic of current psychological theories of AIDS denial and 
stigmatisation strongly suggests that (the availability of ART) will result in 
decreased denial and stigmatisation and in increased safer sexual behaviour, not 
only among those who are infected, but in society at large.” (Stein, 2005) 
 
By reducing the fear of infection and death, ART creates a beneficial spillover 
effect in communities. In the heading to this section, I used the phrase “unwitting 
activist”— in a very real sense, patients on ART exist as visible new symbols of AIDS in 
individuals and communities. In no way is this meant to dismiss the personal and social 
struggle for acceptance that the vast majority of AIDS patients necessarily experience 
before commencing treatment. In the next section I turn to the idea of the patient activist, 
a direct extension of the empowered patient, purposefully seizing upon his/her own new 
physical and mental condition to play a larger role in the fight against HIV/AIDS. 
 
 29
 Effecting change in communities: A task for empowered positive people 
 
In both the communities of Madwaleni and Edendale, positive people were active 
in treatment lobbies and educational campaigns. During the Madwaleni Hospital World 
Aids Day event, the burden of responsibility on positive people to fight against 
discrimination and for treatment was emphasized repeatedly. In Lynne Wilkinson’s 
speech, she credited support groups for the success of the Madwaleni ARV program, and 
reminded support group members of their responsibility to raise awareness in their 
communities and to encourage people to test for HIV. Christina Kopana, speaking on her 
experience as a person living with HIV/AIDS and as a support group leader, declared an 
urgent need to fight discrimination against positive people. (World Aids Day Ceremony, 
1/12/2005) 
Many of the support group leaders I spoke to likewise expressed a sense of 
responsibility towards educating their communities. Sipho of Sbongukuphila spoke of the 
importance of eradicating ignorance towards HIV/AIDS as a crucial step towards 
prevention as well as decreasing stigma in communities. Indeed, the general consensus 
among respondents was that stigma was caused by ignorance more than any other reason. 
I suggested to respondents that stigma could come from other factors, such as the 
association of HIV/AIDS with immorality or promiscuity. In reply, they associated 
HIV/AIDS stigma with fear (caused by ignorance) or superstition, rather than with moral 
arguments: 
 
“I have disclosed my status, everyone knows I am positive. And 
sometimes people don’t dare to talk to me. They think if they touch my gate they 
will also become HIV positive.” (Molly Kubheka, 21/11/05) 
 
“They hear that the numbers are so high, that everyday more people are 
getting infected, so they say you are wrong when you tell them that you can’t get 
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 HIV from just talking to me or holding my hand.” (Molly Kubheka, 24/11/05) 
 
“The positive people and their buddies must go into the community and 
talk to their neighbours, and spread the message. Then we can end the rumours 
about the witch doctors.” (Sipho Mncwabe, 24/11/05) 
 
“There was a woman who came in with her sister, who is positive, and she 
was so worried about getting infected. After I explained to her that it’s okay to 
share your cups and bowls, but just be careful about blood, she was so relieved 
and happy. So we are working to fight that sort of ignorance.” (Anemari 
Buitendach, 29/11/05) 
 
“People have a lot of wrong information. When sometimes there are a mix 
of people in my house, I try to hold some education, and tell people about 
HIV/AIDS, how you can get infected.” (Zameka Ntibane, 29/11/05) 
 
In the Madwaleni HIV/ARV programme, positive people—both those enrolled in 
the programme, and those already on ARVs— are involved in the hospital campaign to 
encourage testing. At support group meetings it is common to see positive people 
wearing the badge that reads: “Ndilixilongile igazi le-HIV. Wena?” (I have had my blood 
tested for HIV. Have you?) The hospital has formally hired two participants in the ARV 
program as permanent staff. They work on an equal footing with community health 
workers, the ARV clinician, the site coordinator, nurses and counselors. I spent a 
morning with Christina, on ARVs since March, and now a permanent member of the 
Madwaleni HIV/ARV team. Our task that morning was to go around to the wards and the 
waiting rooms in the hospital with pamphlets, and encourage people to take the rapid test 
for HIV.   
As I suggested in the previous section, the existence of treatment has the potential 
to increase the effectiveness of educational and awareness campaigns within 
communities. However, the fact that positive people are taking it upon themselves to 
educate their communities is a phenomenon that warrants further exploration. 
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 Why are so many positive people involved in HIV/AIDS activism? Positive 
people on ARV programmes are acutely aware that they possess a wealth of knowledge 
that remains inaccessible to many. They recognize that the AIDS epidemic is spiraling 
out of control, and that government and international responses to the crisis have been 
weak and incompetent. Their motivation for involvement thus emerges from a deep 
understanding of the epidemic and empathy for those infected and affected by it. This 
understanding is directly facilitated, even created, by the processes surrounding ARV 
treatment. 3
The active involvement of positive people in HIV/AIDS activism speaks in direct 
defiance of reductionist, flawed conceptions of “primary healthcare”, which situate the 
patient as a static entity in relation to “health promotion” strategies, ignoring the agency 
of the patient to influence the events that shape behaviour and decision-making: 
 
“It suggests that the language (of flawed conceptions of primary 
healthcare) may have the effect of making the people health promoters work with 
passive actors who have no control over events: health promotion is something 
that happens to them.” (Baum & Sanders, 1995) 
 
Within this framework, patient-led activism is at bottom a declaration of patients’ 
abilities to make decisions about their own condition. This comes from the tradition of 
the TAC’s “Campaign for Openness” in the early 1990s. (Mbali, 2005) The movement 
instilled a sense of pride and self-respect in positive people, and gave them a public voice 
in demanding the right to treatment and respect. Mbali writes, 
 
“From a mere handful of openly HIV positive white gay activists in the 
                                                          
3 In my conversations with Molly, Christina and Busiswa, they constantly reminded me of the magnitude of 
the epidemic, and the massive ignorance surrounding it. Christina in particular repeatedly declared, during 
one of our conversations, “one out of four people in the Eastern Cape are HIV positive, and only a quarter 
of them know it.”  
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 early 1990s, in the first years of the 21st century… TAC’s protests would come to 
consist of a humn sea of thousands of HIV positive and HIV negative activists 
wearing t-shirts proudly proclaiming “HIV POSITIVE.” (2005) 
 
In 2003, Zackie Achmat declared that HIV positive people do not demand pity; they 
demand rights. (Mbali, 2005) Thus our understanding of the movement by prominent 
PLWAs within support groups to promote awareness and education on HIV/AIDS must 
also be linked to their demand for rights—the right to remain a social participant in their 
community despite illness, their right to be treated with respect and understanding, and 
their right to lead fulfilling lives despite being infected with HIV. What treatment has 
done, then, is provide the physical, psychological and intellectual support and agency 
needed by positive people to organize and effectively demand these rights. 
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 IV. Beyond empowerment: reconceptualizing the role of public health in South 
Africa 
 
 
The paradigm of patient empowerment: Responsible for good health, not blamed for ill 
health 
 
I wish to suggest in this section that ARV treatment as it is currently 
conceptualized provides an opportunity to interrogate the assumptions underlying current 
healthcare systems, and rethink the role of public health in community development and 
nation-building. The restructuring of healthcare systems is beyond the scope of this 
paper, although there has been a great deal of scholarly research into the relationship 
between ARV programmes and the primary healthcare framework. Here, I hope to 
highlight the impact of treatment on the ways in which we conceptualize patient agency 
and the potential for agency to translate into change. I also suggest that taking lessons 
from ARV programmes requires a deeper understanding of the relationship between care 
and agency, and agency and change. 
There are several important ways in which aspects of current ART models 
embody the philosophy of primary healthcare4. Firstly, it signifies a shift away from 
“prevention-only“ that, by promoting “life-skills” and informed decision-making, ignore 
the social context of decision-making. Implicitly, pure “prevention” strategies establish 
the “responsibilisation” , or blame, of individuals for their own ill health. (Petersen & 
Swartz, 2002)  
In contrast, by seeking to understand and change social conditions impeding 
successful treatment, the primary care model recognizes constraints on patients’ choices 
and power in social situations. Furthermore, conceptualizing treatment as inextricably 
                                                          
4 A model long recognized to be moribund or an “experiment that failed”, despite good efforts to the 
contrary. (Sanders & Werner, 1997) 
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 linked to prevention efforts recognizes deeper, more complex psychosocial factors that 
influence perceptions of disease and reactions to education and information. Recognizing 
the psychological logic of stigma and the effect of treatment on this “logic” is one case in 
point; understanding patient adherence as a function of the patient’s own psychosocial 
condition is yet another. 
More significantly, by involving the patient and other support networks more 
extensively in the treatment process, treatment implicitly subverts the power differential 
that exists in the conventional doctor-patient relationship. Writing about this “unequal 
power differential,” Petersen and Swartz note: 
 
“This approach is reflective of the dominance of scientific rationality over 
emotional and moral dimensions of illness. It is, however, antipathetic to the 
notion of ‘empowerment’ which underpins health promotion and arguably the 
success of psychological interventions.” (2002) 
 
In ARV programmes, the subversion of “expert” medical power begins with and 
takes place through the process of patient education, counselling, disclosure and finally 
treatment. The involvement of HIV-positive people in established treatment programmes, 
working side by side with healthcare workers and professionals, attests to the leveling of 
that power. In patient-led activism, the subversion of medical power demands that the 
voices of positive people are heard and respected within communities, in the public 
sphere, and in policy-making surrounding HIV/AIDS. This is particularly important in 
the HIV/AIDS epidemic, where the distribution of physical suffering correlates strongly 
to distributions of poverty, gender inequality, and other experiences of social and 
psychosocial suffering.  
The move from a healthcare philosophy which places the blame of poor health on 
individual belligerence and ignorance, to one which accords the individual the knowledge 
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 and support required for him/her to take responsibility for his/her own health, may seem 
like little more than a play on words. Yet in terms of health policy and structures of 
delivery, it makes a world of a difference.  It may be that the latter model stands as the 
only viable way by which healthcare—especially ARV care and treatment—can be 
extended fairly successfully to the vast numbers of people who need it.5
 
Taking lessons from ART: Exploring the meaning of “empowerment” 
To truly take lessons from the ARV rollout to strengthen existing health systems 
in South Africa, one must assess the fundamental assumptions underlying both existing 
health systems, and successful ARV treatment models. As a part of a national health 
system, HIV/ARV programmes constantly experience a tension between national health 
policy and localised ARV treatment initiatives. Some have pointed out that the 
government has yet to recognize the importance of support networks for the sick, thereby 
systematically neglecting the well-being of those who provide the support—nurses, 
home-based carers, community workers. (Stein et al, 2005) Others resist the “over-
medicalization” of HIV/AIDS care and argue against the “attraction towards a ‘magic 
bullet’ or technological solution” that shafts a multisectoral response to HIV/AIDS. 
(Chopra, 2005) 
 At bottom, these critiques speak to fundamental differences between existing 
localized ARV programmes, and the current governmental framework: differences in 
how HIV/AIDS itself is conceptualized, and in how the person living with HIV/AIDS is 
conceptualized in relation to the disease, his/her community, and to healthcare workers.  
                                                          
5 In my interview with Andrew Boulle, a doctor at the HIV/ARV clinic in Khayelitsha and a researcher at 
the UCT medical school,  he referred to this as a “revolution” in healthcare, noting that “you can’t police 
people forever.” In this sense empowerment-based care appears to be the only way to provide a complex, 
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 Therefore, the acceptance that patient empowerment must needs sit at the centre of a 
primary healthcare approach entails also a consideration of what empowerment means in 
different settings: That is, how healthcare can and should marshall forces of individual 
agency and community cohesion in improving health. The closely-knit, supportive 
community does not form of its own accord; it is a result of a process of accepting 
members of their community living with HIV/AIDS, understanding and learning more 
about the disease, and finally taking personal and collective responsibility towards the 
health of communities. Currently the TAC acts as the agent of organisation in several 
communities; but the TAC as a grassroots organization—and one regarded by the 
government as adversarial—lacks the wherewithal to reach the number of communities 
and effect the level of change it desires. (Interview with Gilles van Cutsem, 16/11/05; 
Interview with Andrew Boulle, 07/12/05) Taking lessons from the empowerment model 
then necessitates the establishment of means of communication between the state and 
community experience and activism, where communities can truly be given a voice and a 
hand in improving healthcare and health education.  
Building a stronger health system that integrates ARV care, then, requires more 
than simply “reclaiming” in theory the focus of healthcare on the patient, and the 
patient’s experience of disease; it requires a strong reevaluation of what empowerment 
means and how it manifests itself in individuals and communities, and the new 
responsibilities of the state to that empowerment.  
                                                                                                                                                                             
lifelong regimen on a large scale without massive defaults or personnel deployment. 
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 Recommendations for Further Study 
 
In the course of this study, I spoke to numerous healthcare workers—be they 
doctors, nurses, clinicians, counsellors, or educators. Most, if not all of them, attested to 
the profound sense in which ARV treatment had radically transformed HIV/AIDS care, 
their interactions with their patients, and their personal experience of caring for the sick. 
At the same time, most of them—especially clinicians, nurses, and counsellors working 
with populations that had poor access to health services or patients dealing with 
discrimination from family members and neighbours—expressed a great sense of 
frustration at the lack of resources and support they had on hand to help the sick in their 
communities. A study that examined the impact of ART provision on healthcare workers 
would not only shed light upon post-ART medical relationships, but also provide insight 
into studies on scaling up ART and strengthening the primary care framework. 
Another interesting area of study is the role of traditional healers in HIV/AIDS 
care. In my conversation with Marcus McGilvray from BRHC, he pointed out that in 
general, when people in rural communities get sick, the first person they visit is their 
neighbour or close family. The second person they visit is the sangoma, traditional 
healer. Yet little or no efforts have been made to educate traditional healers about ARV 
treatment and HIV/AIDS care in general, due to the power embedded in that cross-
cultural interaction. More broadly, this phenomenon suggests that a study into 
information networks around the sick and the social and cultural processes by which 
behavioural decision-making takes place.  
Other ways of furthering this particular study could include a focus on stigma in 
communities and a study of the logic and nature of that stigma.  A study of the 
effectiveness of training and counseling methods for HIV-positive people in resource-
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 poor settings would inform many of the observations and inferences made in this paper. 
Lastly, a study of patient-led activism and the impact of that form of activism on 
conceptualizing and achieving the right to health would provide great insight into theories 
of rural resistance and of social movements. This study might also examine the role of 
treatment and patient-led activism in strengthening political sensibilities in rural/ peri-
urban areas, as well as democratic institutions as a whole. 
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 Conclusion 
 
In this study, I have explored patient participant in an ARV programme as a 
journey of empowerment—through education, the building of self-respect and 
confidence, psychological acceptance and physical strengthening, and finally a 
heightened awareness of one’s voice and one’s agency in using that voice to demand and 
persuade change. Clinicians, community health workers, and counsellors alike have 
spoken to me of the spectacular impact ARV treatment has had on their patients, both 
physically and psychologically; as well as on stigma and discrimination in communities.  
As I noted in my recommendations for further study, the task ahead remains daunting. 
Numerous questions remain—largely revolving around how to scale up antiretroviral 
therapy in South Africa, and how to integrate ART into the national healthcare 
framework. Much of this work will involve systems research and planning, as well as 
economic and human resource evaluation. However, underlying healthcare reform must 
be a rethinking of the concept of “health”, and by extension a rethinking of how the sick 
are structurally defined in healthcare systems.  
The notion that patient empowerment contributes tremendously to the success of 
ARV programmes, and has positive spillover effects for the community at large, suggests 
that we should no longer consider the viability of healthcare systems to be contingent 
upon theoretical models of “cost-effectiveness” or “sustainability”, which treat the patient 
as a static, passive recipient of healthcare. (Petersen & Swartz, 2002) To the contrary, if 
the patient is considered as a partner in healthcare who can be empowered, public health 
can reclaim its original goal of improving the health of communities as a whole—by 
treating ill health, the conditions that perpetuate ill health and, correspondingly physical, 
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 psychological and social suffering caused by ill health. (Petersen & Swartz, 2002) Still 
others suggest that there is no other viable way of providing healthcare, especially ARV 
treatment, to large numbers of people if they cannot take responsibility  
Even after we accept that patient empowerment must be the underlying 
philosophy to building a strong primary healthcare model, the how of empowerment 
proves even more complex than the why. ARV treatment is still extremely young in 
South Africa, and the number of people on treatment is but a small fraction of those who 
require treatment presently, and will require treatment in the following years. Those who 
do manage to navigate the difficulties of their environment to enroll in an ARV 
programme appear to have done exceedingly well; less is known about those who have 
not. We know that patients can be empowered; the next challenge is how to best educate 
and counsel the far larger numbers of people who thus far have not navigated through to 
highly inaccessible services to obtain treatment. (Interview with Andrew Boulle, 
07/12/05) 
The potential for a strong ideological association between healthcare delivery and 
social transformation has implications not only for the nature of healthcare reforms, but 
also developmental strategies in the new South Africa. The lack of political will has been 
frequently raised as the root of the sauntering progress of ARV roll-out in South Africa. 
Stronger state commitment to the social role of healthcare could create opportunities for 
education and access that grassroots social movements—even well-organized, deeply 
influential movements like the Treatment Action Campaign—cannot create for 
themselves. Even in Khayelitsha, where the TAC is arguably the most active, messages 
have not broken through completely; a sizeable amount of people still do not know what 
the TAC stands for. (Interview with Andrew Boulle, 07/12/05) The use of state-owned 
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 media to remind patients to take their medications is an example of what stronger state 
commitment can achieve; having political leaders speak up about their status is another 
case in point.  (Interview with Herman Reuter, AIDS Bulletin, March 2005; Interview 
with Andrew Boulle, 07/12/05)  
Finally, recognising the responsibilities of public health necessitates the linking of 
public health to other spheres of social experience (or social suffering). It requires an 
awareness of other modern day struggles—for land, housing, access to education, and 
privatization of public service, to name a few. As Joia Mukherjee puts it, “as physicians 
we should also be activists against the policies that we know are hurting our patients.” 
(Interview with AIDS Bulletin, September 2005) But the physican activist— or for that 
matter, the health activist of any form—can only do so much in situations of extreme 
resource deprivation and lack of support.6 In the final analysis, only the “synergy 
between state response and community activism” can effect changes in the healthcare 
system that generate positive effects in the communities that either labours to serve. 7
  
                                                          
6 There are of course strategies of mobilization and legal activism that have in the past been extremely 
effective. The TAC’s lawsuit and civil disobedience campaign against the state arguably led to the 
government’s recent commitment to an ARV rollout. It may be less feasible, however, to suggest that 
grassroots activism in local community settings – especially settings of resource constraint—can have the 
influence or impact that the TAC does in its urban, intellectual-led movement.  
7 In my interview with Andrew Boulle, he used the phrase “synergy between state response and community 
activism” in reference to the missed opportunity—due to government intransigience and AIDS denialism—
to fight the AIDS pandemic both from the top down and the ground up. 
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 Appendix: Interview Questions 
 
Informal Interviews with support group leaders/ community health workers, 20/11/05-
1/12/05 
(Molly Kubheka, Nokuthula Biyela, Sipho Mncwabe, Christina Kopana, Busiswa Joya, 
Zameka Ntibane) 
 
 In my time in Edendale and Madwaleni I had the chance to interact on a day-to-
day basis for four or five days with the healthcare workers. Often informal interviews 
took place in between patients in counselling rooms, or on trips to the clinic. In these 
interviews I did not ask a specific set of questions, but directed the conversation to a few 
areas of interest.  
 
Topics raised: 
- Adherence—How difficult is it to establish adherence, and why do people default 
on life-saving treatment? 
- Disclosure—how do you help people to disclose their status? Why is this so 
important for treatment? 
-  
- How do you see your role as a support group leader/ community health worker in 
the fight against HIV/AIDS? 
- What do you think should be done to  reduce stigma in your community?  
- How has your experience as a support group leader/ community health worker 
changed after ARVs are available?  
- Why are support groups so important in ARV treatment? How much time is spent 
in support groups? 
 
Informal Interview with Lynne Wilkinson, site administrator for Madwaleni HIV/ARV 
programme, 28/11/05 
 
- What are the different aspects of the HIV/ARV programme at Madwaleni? 
- Did Madwaleni build the support networks in the community or were they pre-
existing? 
- Has ARV treatment had an impact on stigma, in your opinion? 
 
Focus Group with BroadReach Healthcare team in Edendale, 23/11/05 
(Themba Duze, Regional Coordinator Gauteng; Bongani Nkosi, Regional Coordinator 
Mpumalanga; Zandile Wanda, Regional Coordinator KZN) 
 
- What is your personal background and how did you enter the field of HIV/AIDS? 
- Can you speak a bit about the philosophy of BRHC, the idea of the public-private 
partnership? 
- It has been said that the public-private partnership idea has been around for a long 
time, but never quite been implemented successfully. What do you think? 
- What is your perception of stigma in the communities you work in? Do you think 
it has changed after BRHC entered the community with ARVs? 
- What are adherence rates like? In your experience what helps adherence and what 
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 makes people default? 
 
Interview with Gilles van Cutsem, 16/11/05 
- What is your professional background with regard to HIV/AIDS work?  
- How are ARVs being delivered in  Khayelitsha? What are the processes that 
patients have to go through? 
- What is the difference to you, treating patients before and after ARVs became 
available? 
- What was the level of knowledge about HIV/AIDS in the community before MSF 
arrived, and the level of stigma? 
- What is the philosophy of the ARV treatment programme? 
- How do you see medical treatment in the greater context of social conditions e.g. 
poverty, malnutrition, unemployment? 
- What role do the lay counsellors, support group leaders, and treatment literacy 
counsellors have vis-à-vis yourself, the doctors? 
- How closely do you work with the TAC and other activist organizations? 
- What are the reasons for poor adherence, when it happens, in Khayelitsha? What 
are the reasons for such good adherence statistics? 
- How do you see the expansion of ART care in South Africa? 
 
Interview with Andrew Boulle, 07/12/05 
 
- How does the MSF model compare to the ARV rollout in other parts of South 
Africa, or for that matter the Madwaleni model and the BroadReach model? 
- What would the health system ideally look like, if HIV/AIDS care and ART in are 
integrated into the system? 
- How different has it been treating patients pre and post-ARVs? 
- Has it changed the way you interact with patients? 
- What is the role of the TAC in Khayelitsha, and do you think that there are many 
positive people involved in HIV/AIDS activism? 
- To what would you attribute the high rates of adherence that MSF reports? 
- What sort of leadership does the HIV/AIDS movement need? Can the TAC 
provide this leadership?  
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